NNRTIs

CL 403 Pill - yellow capsule-shape, 19mm

Pill with imprint CL 403 is Yellow, Capsule-shape and has been identified as Nevirapine Extended-Release 400 mg. It is supplied by Cipla USA Inc.

Nevirapine is used in the treatment of HIV Infection; Reduction of Perinatal Transmission of HIV and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Nevirapine (Nevirapine [ ne-vye-ra-peen ])-CL 403-400 mg-Yellow-Capsule-shape

Nevirapine
Generic Name: nevirapine [ ne-vye-ra-peen ]
Imprint: CL 403
Strength: 400 mg
Color: Yellow
Size: 19.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: NNRTIs
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 69097-0403 (Discontinued)
Inactive Ingredients: Lactose monohydrate, Hypromelloses, Ferric oxide yellow, Magnesium stearate,
Latest News
Related Drugs